KHAN SADIQ (Chief Commercial Officer) received a stock award from TEVOGEN BIO HOLDINGS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/1/2025ACC: 0001062993-25-012331
Officer· Chief Commercial Officer
Since Feb 2024
+200K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
200K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+200K
Price / share
—
Trade value
—
% of position
20.6%
6/27/2025
969.62K→1.17M
Total
Net shares
+200K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/27/2025 | A · Award | +200K | — | — | 20.6% | 969.62K | 1.17M |
| Total | +200K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported